SCHEMBL29700330

SCHEMBL29700330

O=[N+]([O-])c1ccc2occc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.47
MAOB P27338 3/20 0.46
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAOA P21397 2/20 0.46
ALDH1A1 P00352 3/20 0.46
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
POLB P06746 1/20 0.45
PAX8 Q06710 1/20 0.45
PSMB8 P28062 1/20 0.44
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
PTPN1 P18031 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428529 1.00 CYP2A6 (0.47) CYP2A6MAOBRAB9ANPC1SMN1; SMN2
SCHEMBL27612022 0.93 MAOB (0.49) CYP2A6MAOBRAB9ANPC1SMN1; SMN2
Butane SCHEMBL5333879 0.92 CA12 (0.44) CYP2A6MAOBRAB9ANPC1SMN1; SMN2
SCHEMBL5329937 0.89 RAB9A (0.43) CYP2A6MAOBRAB9ANPC1SMN1; SMN2
Propionic Acid SCHEMBL27841948 0.86 MAOA (0.47) MAOBRAB9ANPC1SMN1; SMN2MAOA
SCHEMBL3799970 0.85 MAPT (0.46) CYP2A6RAB9ANPC1SMN1; SMN2MAOA
SCHEMBL30469300 0.83 DYRK1A (0.49) MAOBRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL20557631 0.83 DYRK1A (0.49) MAOBRAB9ANPC1SMN1; SMN2ALDH1A1
Ethoxycarbonyl Group SCHEMBL27813205 0.83 CYP2A6 (0.41) CYP2A6MAOBRAB9ANPC1SMN1; SMN2
SCHEMBL28207356 0.82 HPGD (0.51) RAB9ASMN1; SMN2ALDH1A1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031243-A1 GLUE DEGRADERS AND METHODS OF USE THEREOF Novartis AG (CH) 2022-07-27 EP disclosed